iTonis Inc. | Balance Sheet

Fiscal year is December-November. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2.40
2.70
2.30
9.70
15.20
5
Other Current Assets
276.30
2.10
2.10
2.10
2.10
2.10
Total Current Assets
278.70
4.80
4.40
11.80
17.30
7
Net Property, Plant & Equipment
3.20
1.80
0.40
-
-
-
Intangible Assets
640.00
300.00
324.00
324.00
13.00
13
Other Assets
-
18.00
18.00
32.70
28.10
37.20
Total Assets
921.90
324.60
346.70
368.50
58.40
57.20
ST Debt & Current Portion LT Debt
-
464.40
566.70
651.80
690.60
Accounts Payable
145.20
-
-
-
-
Income Tax Payable
3.20
4.00
4.00
4.80
5.60
Other Current Liabilities
194.40
235.30
221.10
237.50
233.50
Total Current Liabilities
342.70
703.70
791.80
894.10
929.80
Total Liabilities
342.70
703.70
791.80
894.10
929.80
Common Equity (Total)
579.10
379.10
445.60
526.10
871.90
Total Shareholders' Equity
579.10
379.10
445.10
525.60
871.40
Total Equity
579.10
379.10
445.10
525.60
871.40
Liabilities & Shareholders' Equity
921.90
324.60
346.70
368.50
58.40
Preferred Stock (Carrying Value)
-
-
0.50
0.50
0.50

About iTonis

View Profile
Address
22951 Mill Creek Drive
Laguna Hills California 92653
United States
Employees -
Website http://www.itonisholdings.com
Updated 07/08/2019
Itonis, Inc. operates as a holding company, which engages in development and distribution of products to the medical and pharmaceutical industry. Its product includes Emesyl. The company was founded on July 5, 2005 and is headquartered in Laguna Hills, CA.